Search Results - michael+wyatt

3 Results

Sort By:

Abbapolins as Inhibitors and Degraders of Polo-Like Kinases

Reference #: 01593 The University of South Carolina is offering licensing opportunities for Abbapolins as Inhibitors and Degraders of Polo-Like Kinases Background: There are no effective treatments for castration-resistant prostate cancers as all current therapies eventually fail. Invention Description: Novel chemicals called abbapolins are described...

Published: 4/2/2024 | Inventor(s): Campbell Mcinnes, Michael Wyatt, Danda Chapagai, Jessy Stafford, Gursanker Ramamoorthy

Keywords(s): abbapolin, drug discovery, peptide, Polo Like Kinase

Category(s): Biomedical and Life Sciences, Health Sciences

Novel Pharmaceutical for Prevention of Bleomycin-Induced Pulmonary Fibrosis

Reference #: 01409 The University of South Carolina is offering licensing opportunities for Novel Pharmaceutical for Prevention of Bleomycin-Induced Pulmonary Fibrosis Background: Hodgkin’s lymphoma is one of the curable cancers and the standard treatment regimen involves combination chemotherapy involving bleomycin. One of the fatal side effects...

Published: 9/4/2022 | Inventor(s): Michael Wyatt, Chloe LeBegue

Keywords(s): bleomycin, bleomycin hydrolase, enzyme, inhaled, protein, pulmonary fibrosis, pulmonary toxicity, pulmonology biotech, pulmonology pharma

Category(s): Chemistry and Biochemistry, Health Sciences

Pharmabiotic Approaches to Treat Phenylalanine Hydroxylase Deficiency

Reference #: 01317The University of South Carolina is offering licensing opportunities for Pharmabiotic Approaches to Treat Phenylalanine Hydroxylase DeficiencyBackground:Approximately 1 in 15,000 persons in the US have phenylalanine hydroxylase deficiency. It is stated in the American College of Medical Genetics clinical practice guidelines for the...

Published: 8/21/2024 | Inventor(s): Michael Wyatt, Chloe LeBegue, Jacob Massey

Keywords(s):

Category(s): Chemistry and Biochemistry, Health Sciences, Biomedical and Life Sciences